Surge in Pharmaceutical Imports Threatens U.S. National Security as India/China Dominance Grows

Archive, Featured Home Page, Featured Research, Research, Research Hub Articles

KEY POINTS U.S. pharmaceutical imports have risen sharply in the last decade, with imports from China and India skyrocketing. India and China are increasingly the leading U.S. source for generic pharmaceuticals, which account for 91% of all prescriptions written in the U.S. China and India account for 57.6% of total pharmaceutical imports by weight last…

End China Access to U.S. Capital Markets

CPA Applauds Spartz, Sherman Legislative Package to Address China’s Exploitation of U.S. Capital Markets

Archive, Capital Markets, China, CPA News, Featured Home Page, Newsroom, Op-Ed & PR Featured, Press Release, Tax

The legislative package will end tax breaks for Chinese stocks, restrict sanctioned Chinese companies’ access to U.S. capital markets, increase transparency on risks to American corporations, and reduce exposure to these risks for retail investors and other Americans saving for retirement.